1HLL

NMR STRUCTURE OF T3-I2, A 32 RESIDUE PEPTIDE FROM THE ALPHA-2A ADRENERGIC RECEPTOR

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D NOESY	0.9 mM T3-I2 natural abundance; 460 mM D38-dodecylphosphocholine, 50 mM NaCl, 10 mM NaH2PO4, pH 4.5	90% H2O/10% D2O	50 mM NaCl	4.5		303
2	2D TOCSY	0.9 mM T3-I2 natural abundance; 460 mM D38-dodecylphosphocholine, 50 mM NaCl, 10 mM NaH2PO4, pH 4.5	90% H2O/10% D2O	50 mM NaCl	4.5		303
3	2D COSY	0.9 mM T3-I2 natural abundance; 460 mM D38-dodecylphosphocholine, 50 mM NaCl, 10 mM NaH2PO4, pH 4.5	90% H2O/10% D2O	50 mM NaCl	4.5		303
4	2D NOESY	0.9 mM T3-I2 natural abundance; 460 mM D38-dodecylphosphocholine, 50 mM NaCl, 10 mM NaH2PO4, pH 4.5	90% H2O/10% D2O

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	UNITY	800

NMR Refinement
Method	Details	Software
simulated annealing in torsion angle space		DYANA

NMR Ensemble Information
Conformer Selection Criteria
Conformers Calculated Total Number
Conformers Submitted Total Number	1

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure solution	DYANA		Guentert
2	processing	XEASY		BARTELS
3	data analysis	NMRPipe		DELAGLIO
4	processing	NMRView		JOHNSON
5	processing	SPSCAN		GLASER
6	refinement	DYANA		Guentert

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.